SEC Form 4 · accession 0001144204-18-018750
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline Sybil Papkoff
Officer — See remarks
Period of report
Apr 2, 2018
Accepted (ET)
Apr 2, 2018 · 6:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $46.75 | Apr 2, 2018 | A | 106,200 | A | — | Apr 2, 2028 | Common Stock | 106,200 | 106,200 | D |
Explanation of responses
- F1Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, April 2, 2019; and the remaining 75% shall vest in 36 equal monthly installments, with the options becoming fully vested on April 2, 2022.
Remarks
SVP-Chief Scientific Officer Microbiome